Form D · Pharmaceuticals
ZABECOR PHARMACEUTICALS, LLC
Bala Cynwyd, PA · CIK 0001267199
Offering snapshot reported Apr 2, 2009 · SEC filing
- Reported sold
- $50K Offering amount: $4M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2009 | Initial | $50,000 | No comparison | Not reported | SEC filing |
| Apr 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 20, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-59464
Source: Form D, filed Apr 2, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlos C. Campbell | Director |
| Zack Friedman | Director |
| Zachary Meisel | Director |
| Alan D. Schreiber | Director, Executive |
| John S. White | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Two Bala Plaza, Suite 300
Bala Cynwyd, PA, 19004
Bala Cynwyd, PA, 19004